LifeMD Shareholders: Important Updates on Recent Lawsuit

Overview of the LifeMD Lawsuit

LifeMD, Inc. (NASDAQ: LFMD) has recently faced significant legal challenges as a result of allegations concerning securities fraud. Investors are now urged to examine their involvement in this class action lawsuit. The firm Glancy Prongay & Murray LLP has announced an important deadline for investors to potentially recover their losses.

Key Events Leading to the Lawsuit

In early August 2025, LifeMD made a crucial disclosure regarding operational issues within its Rex MD business. This announcement came after market hours and signaled a revision in the firm's revenue and adjusted EBITDA guidance for the full year.

Following this revelation, the reaction from investors was swift. On August 6, 2025, the share price plummeted by $5.31, representing a staggering decline of 44.8%, closing at $6.53. This drastic drop has left many investors concerned about their financial futures and has catalyzed this legal action.

The Class Action Details

The class action lawsuit alleges that during the period from May 7, 2025, to August 5, 2025, LifeMD's executives made misleading statements about the company's performance. These statements concealed crucial information related to the company's competitive stance and challenges faced in customer acquisition for its offerings in the obesity treatment segment.

Why Investors Should Act Now

If you've bought shares of LifeMD during this period, it’s vital to understand your rights. The deadline to file a lead plaintiff motion in this class action is set for October 27, 2025. This window offers shareholders a chance to seek justice for any losses incurred due to the alleged misleading information provided by the company's management.

Understanding Your Legal Options

Understanding the reasons behind the company's stock decline is crucial. The complaint indicates that the executives at LifeMD may have overstated their competitive position and revenue projections without properly addressing the increased customer acquisition costs associated with their segments.

If you feel that your investment decisions were influenced by these misleading statements, it is imperative to consider your participation in this lawsuit. Engaging with legal representatives can assist you in navigating this process effectively.

How to Get Involved

Investors looking to learn more about their legal rights in this scenario can reach out to professionals at Glancy Prongay & Murray LLP. For those interested in potentially joining the suit or simply gathering more information, they can contact the firm directly:

Charles Linehan, Esq.
Glancy Prongay & Murray LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Email: shareholders@glancylaw.com
Telephone: 310-201-9150
Toll-Free: 888-773-9224

Conclusion

As the situation with LifeMD develops, it's essential for investors to remain aware of their options and the potential for financial recovery. Monitoring news related to this lawsuit will be important for all stakeholders involved, especially as deadlines approach.

Frequently Asked Questions

What is the lawsuit against LifeMD about?

The lawsuit centers on allegations of securities fraud due to misleading statements made by the company about its performance during a specific period.

What should I do if I invested in LifeMD?

If you invested in LifeMD during the class period, consider reaching out to a legal expert about your options for recovery.

What is the deadline to join the class action?

The deadline to file a lead plaintiff motion is October 27, 2025.

How can I contact the law firm handling the case?

You can contact Glancy Prongay & Murray LLP via email at shareholders@glancylaw.com or call 310-201-9150.

What are the potential outcomes of the lawsuit?

Investors may have the chance to recover losses if the lawsuit is successful and demonstrates that the company misled its investors.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.